Sunshine Biopharma Inc. (SBFMW) stock
SBFMWNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as SBFM
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 10/30
$0.03+0.00 (+2.00%)
Close on Oct 30, 2026Market cap $11.36MP/E –Yield –
Sunshine Biopharma revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Sunshine Biopharma's revenue for the twelve months ending Jun 30, 2026 was $35.35M, down 2.7% year over year. For fiscal 2025 it was $36.31M, up 4.1% from the year before. Over ten years it grew 170.9% a year on average. The highest annual figure on record is $36.31M in fiscal 2025.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $36.31M | +4.1% |
| FY2024 | Dec 31, 2024 | $34.87M | +44.7% |
| FY2023 | Dec 31, 2023 | $24.09M | +454.4% |
| FY2022 | Dec 31, 2022 | $4.35M | +1802.4% |
| FY2021 | Dec 31, 2021 | $228.43K | +219.9% |
| FY2020 | Dec 31, 2020 | $71.41K | +238.1% |
| FY2019 | Dec 31, 2019 | $21.12K | – |
| FY2018 | Dec 31, 2018 | $0 | – |
| FY2017 | Dec 31, 2017 | $0 | – |
| FY2016 | Dec 31, 2016 | $0 | -100.0% |
| FY2015 | Dec 31, 2015 | $1.71K | – |
| FY2014 | Dec 31, 2014 | $0 | – |
| FY2013 | Dec 31, 2013 | $0 | – |
| FY2012 | Dec 31, 2012 | $0 | – |
| FY2011 | Dec 31, 2011 | $0 | – |
| FY2010 | Dec 31, 2010 | $0 | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $9.26M | -1.6% |
| Q1 FY2026 | Mar 31, 2026 | $8.09M | -9.1% |
| Q4 FY2025 | Dec 31, 2025 | $8.58M | -10.6% |
| Q3 FY2025 | Sep 30, 2025 | $9.42M | +11.6% |
| Q2 FY2025 | Jun 30, 2025 | $9.41M | +1.2% |
| Q1 FY2025 | Mar 31, 2025 | $8.90M | +18.0% |
| Q4 FY2024 | Dec 31, 2024 | $9.59M | +24.9% |
| Q3 FY2024 | Sep 30, 2024 | $8.44M | +41.6% |
| Q2 FY2024 | Jun 30, 2024 | $9.30M | +67.3% |
| Q1 FY2024 | Mar 31, 2024 | $7.54M | +54.1% |
| Q4 FY2023 | Dec 31, 2023 | $7.68M | +94.9% |
| Q3 FY2023 | Sep 30, 2023 | $5.96M | +4385.9% |
| Q2 FY2023 | Jun 30, 2023 | $5.56M | +3599.7% |
| Q1 FY2023 | Mar 31, 2023 | $4.89M | +3890.4% |
| Q4 FY2022 | Dec 31, 2022 | $3.94M | +4528.7% |
| Q3 FY2022 | Sep 30, 2022 | $132.81K | +163.6% |
| Q2 FY2022 | Jun 30, 2022 | $150.31K | +184.3% |
| Q1 FY2022 | Mar 31, 2022 | $122.65K | +206.2% |
| Q4 FY2021 | Dec 31, 2021 | $85.12K | +203.9% |
| Q3 FY2021 | Sep 30, 2021 | $50.38K | +193.7% |
| Q2 FY2021 | Jun 30, 2021 | $52.87K | +249.1% |
| Q1 FY2021 | Mar 31, 2021 | $40.06K | +260.8% |
| Q4 FY2020 | Dec 31, 2020 | $28.01K | +165.4% |
| Q3 FY2020 | Sep 30, 2020 | $17.15K | +134.1% |
| Q2 FY2020 | Jun 30, 2020 | $15.15K | +399.3% |
| Q1 FY2020 | Mar 31, 2020 | $11.10K | +5289.3% |
| Q4 FY2019 | Dec 31, 2019 | $10.56K | – |
| Q3 FY2019 | Sep 30, 2019 | $7.33K | – |
| Q2 FY2019 | Jun 30, 2019 | $3.03K | – |
| Q1 FY2019 | Mar 31, 2019 | $206 | -99.8% |
| Q4 FY2018 | Dec 31, 2018 | $0 | – |
| Q3 FY2018 | Sep 30, 2018 | $0 | – |
| Q2 FY2018 | Jun 30, 2018 | $0 | – |
| Q1 FY2018 | Mar 31, 2018 | $91.17K | – |
| Q4 FY2017 | Dec 31, 2017 | $0 | – |
| Q3 FY2017 | Sep 30, 2017 | $0 | – |
| Q2 FY2017 | Jun 30, 2017 | $0 | – |
| Q1 FY2017 | Mar 31, 2017 | $0 | – |
| Q4 FY2016 | Dec 31, 2016 | $0 | – |
| Q3 FY2016 | Sep 30, 2016 | $0 | – |